Waddell & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ATO
QP
AAMU
Waddell & Associates's MRK Position: Q2 2026 in Review
Waddell & Associates increased its Merck (MRK) stake by 2% in Q2 2026, buying an estimated $49.7K and bringing the position to 21,357 shares worth $2.74M. The position accounts for 0.14% of the portfolio, ranked #50.
Waddell & Associates first reported a position in MRK in Q2 2021 and has held it in 21 quarters since. 1,426 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Waddell & Associates held 21,357 shares of Merck worth $2.74M as of Q2 2026.
- Waddell & Associates bought 425 Merck shares in Q2 2026, an estimated $49.7K.
- Merck made up 0.14% of Waddell & Associates's portfolio in Q2 2026, its #50 holding.
- Waddell & Associates first reported a position in Merck in Q2 2021 and has held it in 21 quarters since.
- 1,426 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.